+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

T-cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

T-cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
From
Lung transplant rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Lung transplant rejection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
From
From
From
From
From
From
Ewing Sarcoma Disease - Global Clinical Trials Review, H1, 2021 - Product Thumbnail Image

Ewing Sarcoma Disease - Global Clinical Trials Review, H1, 2021

  • Clinical Trials
  • February 2021
  • 267 Pages
  • Global
From
From
Geriatric Medicines Market 2025-2029 - Product Thumbnail Image

Geriatric Medicines Market 2025-2029

  • Report
  • February 2025
  • 231 Pages
  • Global
From
CXCR4 receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

CXCR4 receptor antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator